Nov Inc
NYSE:NOV
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nov Inc
NYSE:NOV
|
US |
|
M
|
Mulberry Group PLC
XBER:MUY
|
UK |
|
A
|
Accuray Inc
XBER:XEJ
|
US |
|
Lufax Holding Ltd
NYSE:LU
|
CN |
|
F
|
Fresenius Medical Care AG
DUS:FME
|
DE |
Wall St Price Targets
NOV Price Targets Summary
Nov Inc
According to Wall Street analysts, the average 1-year price target for NOV is 22.89 USD with a low forecast of 17.17 USD and a high forecast of 27.3 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOV's stock price target?
Price Target
22.89
USD
According to Wall Street analysts, the average 1-year price target for NOV is 22.89 USD with a low forecast of 17.17 USD and a high forecast of 27.3 USD.
What is the Revenue forecast for Nov Inc?
Projected CAGR
1%
Over the last 13 years, the compound annual growth rate for Revenue has been -5%. The projected CAGR for the next 5 years is 1%.
What is the Gross Profit forecast for Nov Inc?
Projected CAGR
0%
Over the last 13 years, the compound annual growth rate for Gross Profit has been -7%. The projected CAGR for the next 5 years is 0%.
What is the Operating Income forecast for Nov Inc?
Projected CAGR
-1%
Over the last 13 years, the compound annual growth rate for Operating Income has been -12%. The projected CAGR for the next 5 years is -1%.
What is the Pre-Tax Income forecast for Nov Inc?
Projected CAGR
30%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been -15%. The projected CAGR for the next 3 years is 30%.
What is the Net Income forecast for Nov Inc?
Projected CAGR
29%
Over the last 13 years, the compound annual growth rate for Net Income has been -20%. The projected CAGR for the next 5 years is 29%.
